SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.

Mohammad AH, Mohammad SH, Alsaaty MH

Open source

DOI
10.11005/jbm.25.995
Published
2026 Aug
Container
Journal of bone metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.11005/jbm.25.995,
  title = {SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.},
  author = {Mohammad AH and Mohammad SH and Alsaaty MH},
  year = {2026},
  journal = {Journal of bone metabolism},
  doi = {10.11005/jbm.25.995},
  url = {https://doi.org/10.11005/jbm.25.995}
}

RIS

TY  - JOUR
TI  - SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.
AU  - Mohammad AH
AU  - Mohammad SH
AU  - Alsaaty MH
PY  - 2026
JO  - Journal of bone metabolism
DO  - 10.11005/jbm.25.995
UR  - https://doi.org/10.11005/jbm.25.995
ER  - 

APA

AH, M., SH, M., & MH, A. (2026). SGLT2 Inhibitors: Dual Effects on Erythropoiesis and Bone Metabolism.. Journal of bone metabolism. https://doi.org/10.11005/jbm.25.995

Source records